Extract from the Register of European Patents

EP Citations: EP1928903

Cited inInternational search
Type:Non-patent literature
Publication information:[XY]   BORSELLO TIZIANA ET AL: "A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia.", NATURE MEDICINE. SEP 2003, vol. 9, no. 9, September 2003 (2003-09-01), pages 1180 - 1186, XP002366119, ISSN: 1078-8956 [X] 1-13 * the whole document *[Y] 14-23
DOI: http://dx.doi.org/10.1038/nm911
Type:Non-patent literature
Publication information:[XY]   BONNY C ET AL: "Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death", DIABETES, NEW YORK, NY, US, vol. 50, no. 1, January 2001 (2001-01-01), pages 77 - 82, XP002274267, ISSN: 0012-1797 [X] 1-13 * the whole document *[Y] 14-23
DOI: http://dx.doi.org/10.2337/diabetes.50.1.77
Type:Non-patent literature
Publication information:[XY]   BARR R K ET AL: "IDENTIFICATION OF THE CRITICAL FEATURES OF A SMALL PEPTIDE INHIBITOR OF JNK ACTIVITY", JOURNAL OF BIOLOGICAL CHEMISTRY, THE AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, INC.,, US, vol. 277, no. 13, 29 March 2002 (2002-03-29), pages 10987 - 10997, XP001155759, ISSN: 0021-9258 [X] 1-6 * table 1 *[Y] 7-23
DOI: http://dx.doi.org/10.1074/jbc.M107565200
Type:Non-patent literature
Publication information:[Y]   VIVES E ET AL: "A TRUNCATED HIV-1 TAT PROTEIN BASIC DOMAIN RAPIDLY TRANSLOCATES THROUGH THE PLASMA MEMBRANE AND ACCUMULATES IN THE CELL NUCLEUS", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 272, no. 25, 1997, pages 16010 - 16017, XP002931299, ISSN: 0021-9258 [Y] 7-23 * figure 1 *
DOI: http://dx.doi.org/10.1074/jbc.272.25.16010
Type:Non-patent literature
Publication information:[Y]   BORSELLO TIZIANA ET AL: "Use of cell-permeable peptides to prevent neuronal degeneration.", TRENDS IN MOLECULAR MEDICINE. MAY 2004, vol. 10, no. 5, May 2004 (2004-05-01), pages 239 - 244, XP002366120, ISSN: 1471-4914 [Y] 1-23 * the whole document *
DOI: http://dx.doi.org/10.1016/j.molmed.2004.03.008
Type:Non-patent literature
Publication information:[Y]   BONNY CHRISTOPHE ET AL: "Targeting the JNK pathway as a therapeutic protective strategy for nervous system diseases.", REVIEWS IN THE NEUROSCIENCES. 2005, vol. 16, no. 1, 2005, pages 57 - 67, XP009061133, ISSN: 0334-1763 [Y] 1-23 * the whole document *
Type:Non-patent literature
Publication information:[Y]   DATABASE UniProt 28 February 2003 (2003-02-28), XP002366175, retrieved from EBI Database accession no. Q9WVI9 [Y] 1-23 * column A *
Cited inExamination
Type:Non-patent literature
Publication information:  TACHIBANA H ET AL: "JNK1 is required to preserve cardiac function in the early response to pressure overload", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 343, no. 4, 19 May 2006 (2006-05-19), pages 1060 - 1066, XP024924816, ISSN: 0006-291X, [retrieved on 20060519], DOI: DOI:10.1016/J.BBRC.2006.03.065
DOI: http://dx.doi.org/10.1016/j.bbrc.2006.03.065
Type:Non-patent literature
Publication information:  KUAN CHIA-YI ET AL: "A critical role of neural-specific JNK3 for ischemic apoptosis.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 9 DEC 2003 LNKD- PUBMED:14657393, vol. 100, no. 25, 9 December 2003 (2003-12-09), pages 15184 - 15189, ISSN: 0027-8424
Type:Non-patent literature
Publication information:  CHANG LUFEN ET AL: "JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins.", DEVELOPMENTAL CELL APR 2003 LNKD- PUBMED:12689591, vol. 4, no. 4, April 2003 (2003-04-01), pages 521 - 533, ISSN: 1534-5807
Type:Non-patent literature
Publication information:  CHOI HONG SEOK ET AL: "c-Jun N-terminal kinase 1 phosphorylates Myt1 to prevent UVA-induced skin cancer.", MOLECULAR AND CELLULAR BIOLOGY APR 2009 LNKD- PUBMED:19204086, vol. 29, no. 8, April 2009 (2009-04-01), pages 2168 - 2180, ISSN: 1098-5549
Type:Non-patent literature
Publication information:  WESTWICK J.K. ET AL: "Activation of Jun kinase is an early event in hepatic regeneration.", THE JOURNAL OF CLINICAL INVESTIGATION FEB 1995 LNKD- PUBMED:7860764, vol. 95, no. 2, February 1995 (1995-02-01), pages 803 - 810, ISSN: 0021-9738
Type:Non-patent literature
Publication information:  HUNOT STPHANE ET AL: "JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 13 JAN 2004 LNKD- PUBMED:14704277, vol. 101, no. 2, 13 January 2004 (2004-01-13), pages 665 - 670, ISSN: 0027-8424
Type:Non-patent literature
Publication information:  SUMARA G ET AL: "Jnking atherosclerosis", CMLS CELLULAR AND MOLECULAR LIFE SCIENCES, BIRKHUSER-VERLAG, BA, vol. 62, no. 21, 1 November 2005 (2005-11-01), pages 2487 - 2494, XP019200875, ISSN: 1420-9071, DOI: DOI:10.1007/S00018-005-5253-6
DOI: http://dx.doi.org/10.1007/s00018-005-5253-6
Type:Non-patent literature
Publication information:  JAESCHKE ANJA ET AL: "Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 10 MAY 2005 LNKD- PUBMED:15867147, vol. 102, no. 19, 10 May 2005 (2005-05-10), pages 6931 - 6935, ISSN: 0027-8424
Type:Non-patent literature
Publication information:  BOST FREDERIC ET AL: "The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells", MOLECULAR AND CELLULAR BIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, US, vol. 19, no. 3, 1 March 1999 (1999-03-01), pages 1938 - 1949, XP002169471, ISSN: 0270-7306
Type:Non-patent literature
Publication information:  AHMED SHAFIQ UDDIN ET AL: "Basal cancer cell survival involves JNK2 suppression of a novel JNK1/c-Jun/Bcl-3 apoptotic network.", PLOS ONE 2009 LNKD- PUBMED:19806201, vol. 4, no. 10, 2009, pages e7305, ISSN: 1932-6203